RxDoctor Payments Data

Ronald Shore, MD

Dermatology · Rockville, MDNPI 1144258757

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $98,750 of the $104,671 with a category attached, or 94.3%. Pfizer accounts for 96.2% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2021 at $79,287 and has fallen 99.6% since, to $303 in 2025. Among dermatology clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$104,671in general payments, 2019–2025

Across 158 payments — averaging $662.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$101K
  • AbbVie$772
  • Johnson & Johnson$649
  • Lilly USA, LLC$592
  • Dermavant Sciences, Inc.$430
  • Sanofi$275
  • plus $1K from 15 others
$371,102in research payments, 2019–2025

Across 54 payments — averaging $6872.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$371K

What the payments were for

  • Consulting fees$98,75094%
  • Travel & lodging$1,1961%
  • Food & beverage$4,3354%
  • Education$3900%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$104,671 in reported general payments places this provider in the 90th percentile of 306 dermatology providers in Maryland.

See all dermatology providers in Maryland

Medicare billing

Part B allowed, 2024
$306,817
Medicare patients
525
Services billed
2,755

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc236$3,800
Cephalexin107$3,058
Tacrolimus27$2,951
Clobetasol Propionate53$2,772
Ammonium Lactate127$2,197
Amoxicillin111$1,835
Gentamicin Sulfate41$1,607
Triamcinolone Acetonide259$1,426
Imiquimod51$1,377
Azithromycin106$529
Ketoconazole11$425
Prednisone54$276
ValacyclovirValacyclovir Hcl12$232
Clindamycin Hcl16$122
Ciprofloxacin Hcl14$28

Paid to pharmacies, not to this prescriber.

Other dermatology in Rockville

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →